Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › clindamycin

clindamycin

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of clindamycin

9 trials tracked of clindamycin: 7 in phase 3 or 4 and 2 with published results. The most-cited published study has 5 citations.

9Trials tracked
7Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 4 Phase 3 3 Phase 2 1 Phase 1 1
  1. Phase 4 Antibiotics Usage in Pediatric Orthopaedic Percutaneous Surgery (APOPS) Completed · 5 cited
  2. Phase 3 Trial of Randomized Antibiotic Administration in Percutaneous Nephrolithotomy Completed · 2 cited
  3. Phase 4 Clindamycin Once a Day in Septic Abortion Completed
  4. Phase 4 Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections Completed
  5. Phase 4 AUGMENTIN™ in Dental Infections Completed
  6. Phase 3 Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA Completed
Show 3 more trials
  1. Phase 3 Strategies Using Off-Patent Antibiotics for Methicillin Resistant S. Aureus "STOP MRSA" Completed
  2. Phase 2 Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus Completed
  3. Phase 1 Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile Completed

Showing the 9 most-cited and recently-updated of 9 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Case report review of clindamycin use in a 62-year-old male with Neurofibromatosis type 1 and hematoma
Cardiology Sys. Review
Case report review of clindamycin use in a 62-year-old male with Neurofibromatosis type 1 and hematoma A Rare Bleeding Complication Every NF1 Patient Should Know About
This case report review describes the management of a 62-year-old male with Neurofibromatosis type 1 who presented with a hematoma. The pati…
A sudden pain or unexplained lump in someone with NF1 could signal a life-threatening bleed that needs emergency care right away.
Frontiers May 14, 2026
Meta-analysis of antimicrobial resistance prevalence in Tanzanian hospital pathogens
Infectious Disease Meta-analysis
Meta-analysis of antimicrobial resistance prevalence in Tanzanian hospital pathogens Common Antibiotics Are Failing in Tanzania, New Data Reveals
This systematic review and meta-analysis synthesizes data from 28 studies on antimicrobial resistance in clinically relevant pathogens withi…
This research shows that common antibiotics are losing their power in Tanzania, urging a critical update to how infections are treated.
Apr 22, 2026
Linezolid vs clindamycin shows no ICU or hospital stay difference in severe SSTIs
Infectious Disease Meta-analysis
Linezolid vs clindamycin shows no ICU or hospital stay difference in severe SSTIs For severe skin infections, does one antibiotic keep you out of the hospital longer?
A systematic review and meta-analysis of patients with severe or necrotizing skin and soft tissue infections found no significant difference…
For severe skin infections, using linezolid instead of clindamycin does not help patients leave the hospital faster, though it may lower kid…
Apr 2, 2026